Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

aSynPEP-DB, a database of biogenic peptides for inhibiting α-synuclein aggregation

  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Bárcenas, Oriol|||0000-0002-8439-4005
  • Iglesias, Valentin|||0000-0002-6133-0869
  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Manglano-Artuñedo, Zoe
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Burdukiewicz, Michał|||0000-0001-8926-582X
  • Ventura, Salvador|||0000-0002-9652-6351
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder, yet effective treatments able to stop or delay disease progression remain elusive. The aggregation of a presynaptic protein, α-synuclein (aSyn), is the primary neurological hallmark of PD and, thus, a promising target for therapeutic intervention. However, the lack of consensus on the molecular properties required to specifically bind the toxic species formed during aSyn aggregation has hindered the development of therapeutic molecules. Recently, we defined and experimentally validated a peptide architecture that demonstrated high affinity and selectivity in binding to aSyn toxic oligomers and fibrils, effectively preventing aSyn pathogenic aggregation. Human peptides with such properties may have neuroprotective activities and hold a huge therapeutic interest. Driven by this idea, here, we developed a discriminative algorithm for the screening of human endogenous neuropeptides, antimicrobial peptides and diet-derived bioactive peptides with the potential to inhibit aSyn aggregation. We identified over 100 unique biogenic peptide candidates and ensembled a comprehensive database (aSynPEP-DB) that collects their physicochemical features, source datasets and additional therapeutic-relevant information, including their sites of expression and associated pathways. Besides, we provide access to the discriminative algorithm to extend its application to the screening of artificial peptides or new peptide datasets. aSynPEP-DB is a unique repository of peptides with the potential to modulate aSyn aggregation, serving as a platform for the identification of previously unexplored therapeutic agents. Database URL:.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The role of amphipathic and cationic helical peptides in Parkinson's disease

  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Ventura, Salvador|||0000-0002-9652-6351
Peptides are attracting a growing interest for therapeutic applications in biomedicine. In Parkinson's disease (PD), different human endogenous peptides have been associated with beneficial effects, including protein aggregation inhibition, reduced inflammation, or the protection of dopaminergic neurons. Such effects seem to be connected to the spatial arrangement of peptide side chains, and many of these human molecules share common conformational traits, displaying a distinctive amphipathic and cationic helical structure, which is believed to be crucial for their activities. This review delves into the relationship between these structural properties and the current evidence connecting biogenic peptides to the amelioration of PD symptoms. We discuss their implications in the disease, the different mechanisms of action, their state of validation, and their therapeutic potential.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A3D Model Organism Database (A3D-MODB), a database for proteome aggregation predictions in model organisms

  • Badaczewska-Dawid, Aleksandra E.
  • Kuriata, Aleksander
  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Garcia-Pardo, Javier|||0000-0001-9179-6371
  • Burdukiewicz, Michał|||0000-0001-8926-582X
  • Iglesias, Valentin|||0000-0002-6133-0869
  • Kmiecik, Sebastian|||0000-0001-7623-0935
  • Ventura, Salvador|||0000-0002-9652-6351
Protein aggregation has been associated with aging and different pathologies and represents a bottleneck in the industrial production of biotherapeutics. Numerous past studies performed in Escherichia coli and other model organisms have allowed to dissect the biophysical principles underlying this process. This knowledge fuelled the development of computational tools, such as Aggrescan 3D (A3D) to forecast and re-design protein aggregation. Here, we present the A3D Model Organism Database (A3D-MODB) , a comprehensive resource for the study of structural protein aggregation in the proteomes of 12 key model species spanning distant biological clades. In addition to A3D predictions, this resource incorporates information useful for contextualizing protein aggregation, including membrane protein topology and structural model confidence, as an indirect reporter of protein disorder. The database is openly accessible without any need for registration. We foresee A3D-MOBD evolving into a central hub for conducting comprehensive, multi-species analyses of protein aggregation, fostering the development of protein-based solutions for medical, biotechnological, agricultural and industrial applications.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Aggrescan4D, structure-informed analysis of pH-dependent protein aggregation

  • Bárcenas, Oriol|||0000-0002-8439-4005
  • Kuriata, Aleksander
  • Zalewski, Mateusz|||0000-0002-3436-8829
  • Iglesias, Valentin|||0000-0002-6133-0869
  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Firlik, Grzegorz
  • Burdukiewicz, Michał|||0000-0001-8926-582X
  • Kmiecik, Sebastian|||0000-0001-7623-0935
  • Ventura, Salvador|||0000-0002-9652-6351
Protein aggregation is behind the genesis of incurable diseases and imposes constraints on drug discovery and the industrial production and formulation of proteins. Over the years, we have been advancing the Aggresscan3D (A3D) method, aiming to deepen our comprehension of protein aggregation and assist the engineering of protein solubility. Since its inception, A3D has become one of the most popular structure-based aggregation predictors because of its performance, modular functionalities, RESTful service for extensive screenings, and intuitive user interface. Building on this foundation, we introduce Aggrescan4D (A4D), significantly extending A3D's functionality. A4D is aimed at predicting the pH-dependent aggregation of protein structures, and features an evolutionary-informed automatic mutation protocol to engineer protein solubility without compromising structure and stability. It also integrates precalculated results for the nearly 500,000 jobs in the A3D Model Organisms Database and structure retrieval from the AlphaFold database. Globally, A4D constitutes a comprehensive tool for understanding, predicting, and designing solutions for specific protein aggregation challenges. The A4D web server and extensive documentation are available at . This website is free and open to all users without a login requirement.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A3DyDB, exploring structural aggregation propensities in the yeast proteome

  • Garcia-Pardo, Javier|||0000-0001-9179-6371
  • Badaczewska-Dawid, Aleksandra E.
  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Iglesias, Valentin|||0000-0002-6133-0869
  • Kuriata, Aleksander
  • Kmiecik, Sebastian|||0000-0001-7623-0935
  • Ventura, Salvador|||0000-0002-9652-6351
Background: The budding yeast Saccharomyces cerevisiae (S. cerevisiae) is a well-established model system for studying protein aggregation due to the conservation of essential cellular structures and pathways found across eukaryotes. However, limited structural knowledge of its proteome has prevented a deeper understanding of yeast functionalities, interactions, and aggregation. Results: In this study, we introduce the A3D yeast database (A3DyDB), which offers an extensive catalog of aggregation propensity predictions for the S. cerevisiae proteome. We used Aggrescan 3D (A3D) and the newly released protein models from AlphaFold2 (AF2) to compute the structure-based aggregation predictions for 6039 yeast proteins. The A3D algorithm exploits the information from 3D protein structures to calculate their intrinsic aggregation propensities. To facilitate simple and intuitive data analysis, A3DyDB provides a user-friendly interface for querying, browsing, and visualizing information on aggregation predictions from yeast protein structures. The A3DyDB also allows for the evaluation of the influence of natural or engineered mutations on protein stability and solubility. The A3DyDB is freely available at http://biocomp.chem.uw.edu.pl/A3D2/yeast. Conclusion: The A3DyDB addresses a gap in yeast resources by facilitating the exploration of correlations between structural aggregation propensity and diverse protein properties at the proteome level. We anticipate that this comprehensive database will become a standard tool in the modeling of protein aggregation and its implications in budding yeast.